Kairos Pharma, Ltd. (KAPA)
NYSEAMERICAN: KAPA · Real-Time Price · USD
0.2900
-0.0051 (-1.73%)
At close: Aug 21, 2026, 4:00 PM EDT
0.2653
-0.0247 (-8.52%)
After-hours: Aug 21, 2026, 8:00 PM EDT
Kairos Pharma Market Cap
Kairos Pharma has a market cap or net worth of $6.87 million as of August 21, 2026. Its market cap has decreased by -69.04% in one year.
Market Cap
6.87M
Enterprise Value
4.25M
1-Year Change
-69.04%
Ranking
Category
Stock Price
$0.29
ChartMarket Cap Chart
Since the IPO on September 16, 2024, Kairos Pharma's market cap has decreased from $33.39M to $6.87M, a decrease of -79.42%. That is a compound annual growth rate of -55.94%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 21, 2026 | 6.87M | -53.51% |
| Dec 31, 2025 | 14.78M | -24.29% |
| Dec 31, 2024 | 19.53M | -41.52% |
| Sep 16, 2024 | 33.39M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Acurx Pharmaceuticals | 7.75M |
| Can-Fite BioPharma | 7.70M |
| Exicure | 7.53M |
| Alzamend Neuro | 7.47M |
| Curanex Pharmaceuticals | 7.39M |
| Bolt Biotherapeutics | 7.06M |
| Liminatus Pharma | 6.93M |
| XTL Biopharmaceuticals | 6.58M |